412 related articles for article (PubMed ID: 26371618)
1. Relapse prevention in major depressive disorder: Mindfulness-based cognitive therapy versus an active control condition.
Shallcross AJ; Gross JJ; Visvanathan PD; Kumar N; Palfrey A; Ford BQ; Dimidjian S; Shirk S; Holm-Denoma J; Goode KM; Cox E; Chaplin W; Mauss IB
J Consult Clin Psychol; 2015 Oct; 83(5):964-75. PubMed ID: 26371618
[TBL] [Abstract][Full Text] [Related]
2. Relapse/Recurrence Prevention in Major Depressive Disorder: 26-Month Follow-Up of Mindfulness-Based Cognitive Therapy Versus an Active Control.
Shallcross AJ; Willroth EC; Fisher A; Dimidjian S; Gross JJ; Visvanathan PD; Mauss IB
Behav Ther; 2018 Sep; 49(5):836-849. PubMed ID: 30146148
[TBL] [Abstract][Full Text] [Related]
3. Adding mindfulness-based cognitive therapy to maintenance antidepressant medication for prevention of relapse/recurrence in major depressive disorder: Randomised controlled trial.
Huijbers MJ; Spinhoven P; Spijker J; Ruhé HG; van Schaik DJ; van Oppen P; Nolen WA; Ormel J; Kuyken W; van der Wilt GJ; Blom MB; Schene AH; Donders AR; Speckens AE
J Affect Disord; 2015 Nov; 187():54-61. PubMed ID: 26318271
[TBL] [Abstract][Full Text] [Related]
4. The effectiveness and cost-effectiveness of mindfulness-based cognitive therapy compared with maintenance antidepressant treatment in the prevention of depressive relapse/recurrence: results of a randomised controlled trial (the PREVENT study).
Kuyken W; Hayes R; Barrett B; Byng R; Dalgleish T; Kessler D; Lewis G; Watkins E; Morant N; Taylor RS; Byford S
Health Technol Assess; 2015 Sep; 19(73):1-124. PubMed ID: 26379122
[TBL] [Abstract][Full Text] [Related]
5. Prevention of relapse/recurrence in major depressive disorder with either mindfulness-based cognitive therapy or cognitive therapy.
Farb N; Anderson A; Ravindran A; Hawley L; Irving J; Mancuso E; Gulamani T; Williams G; Ferguson A; Segal ZV
J Consult Clin Psychol; 2018 Feb; 86(2):200-204. PubMed ID: 29265831
[TBL] [Abstract][Full Text] [Related]
6. Patients with a preference for medication do equally well in mindfulness-based cognitive therapy for recurrent depression as those preferring mindfulness.
Huijbers MJ; Spinhoven P; van Schaik DJ; Nolen WA; Speckens AE
J Affect Disord; 2016 May; 195():32-9. PubMed ID: 26852095
[TBL] [Abstract][Full Text] [Related]
7. Mindfulness-based cognitive therapy for recurrent depression: A translational research study with 2-year follow-up.
Meadows GN; Shawyer F; Enticott JC; Graham AL; Judd F; Martin PR; Piterman L; Segal Z
Aust N Z J Psychiatry; 2014 Aug; 48(8):743-55. PubMed ID: 24595511
[TBL] [Abstract][Full Text] [Related]
8. A randomized controlled trial of Mindfulness-Based Cognitive Therapy (MBCT) versus treatment-as-usual (TAU) for chronic, treatment-resistant depression: study protocol.
Cladder-Micus MB; Vrijsen JN; Becker ES; Donders R; Spijker J; Speckens AE
BMC Psychiatry; 2015 Nov; 15():275. PubMed ID: 26553106
[TBL] [Abstract][Full Text] [Related]
9. Web-based Mindfulness-based Cognitive Therapy for reducing residual depressive symptoms: An open trial and quasi-experimental comparison to propensity score matched controls.
Dimidjian S; Beck A; Felder JN; Boggs JM; Gallop R; Segal ZV
Behav Res Ther; 2014 Dec; 63():83-9. PubMed ID: 25461782
[TBL] [Abstract][Full Text] [Related]
10. Update to the study protocol for a randomized controlled trial comparing mindfulness-based cognitive therapy with maintenance anti-depressant treatment depressive relapse/recurrence: the PREVENT trial.
Kuyken W; Byford S; Byng R; Dalgleish T; Lewis G; Taylor R; Watkins ER; Hayes R; Lanham P; Kessler D; Morant N; Evans A
Trials; 2014 Jun; 15():217. PubMed ID: 24916319
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness and cost-effectiveness of mindfulness-based cognitive therapy compared with maintenance antidepressant treatment in the prevention of depressive relapse or recurrence (PREVENT): a randomised controlled trial.
Kuyken W; Hayes R; Barrett B; Byng R; Dalgleish T; Kessler D; Lewis G; Watkins E; Brejcha C; Cardy J; Causley A; Cowderoy S; Evans A; Gradinger F; Kaur S; Lanham P; Morant N; Richards J; Shah P; Sutton H; Vicary R; Weaver A; Wilks J; Williams M; Taylor RS; Byford S
Lancet; 2015 Jul; 386(9988):63-73. PubMed ID: 25907157
[TBL] [Abstract][Full Text] [Related]
12. A parallel-group, randomized controlled trial into the effectiveness of Mindfulness-Based Compassionate Living (MBCL) compared to treatment-as-usual in recurrent depression: Trial design and protocol.
Schuling R; Huijbers MJ; van Ravesteijn H; Donders R; Kuyken W; Speckens AE
Contemp Clin Trials; 2016 Sep; 50():77-83. PubMed ID: 27451354
[TBL] [Abstract][Full Text] [Related]
13. Study protocol for a randomized controlled trial comparing mindfulness-based cognitive therapy with maintenance anti-depressant treatment in the prevention of depressive relapse/recurrence: the PREVENT trial.
Kuyken W; Byford S; Byng R; Dalgleish T; Lewis G; Taylor R; Watkins ER; Hayes R; Lanham P; Kessler D; Morant N; Evans A
Trials; 2010 Oct; 11():99. PubMed ID: 20961444
[TBL] [Abstract][Full Text] [Related]
14. Practice of therapy acquired regulatory skills and depressive relapse/recurrence prophylaxis following cognitive therapy or mindfulness based cognitive therapy.
Segal ZV; Anderson AK; Gulamani T; Dinh Williams LA; Desormeau P; Ferguson A; Walsh K; Farb NAS
J Consult Clin Psychol; 2019 Feb; 87(2):161-170. PubMed ID: 30431297
[TBL] [Abstract][Full Text] [Related]
15. Cost-Utility Analysis of Mindfulness-Based Cognitive Therapy Versus Antidepressant Pharmacotherapy for Prevention of Depressive Relapse in a Canadian Context: Analyse coût-utilité de la thérapie cognitive basée sur la pleine conscience contre la pharmacothérapie antidépressive pour prévenir la rechute de la dépression en contexte canadien.
Pahlevan T; Ung C; Segal Z
Can J Psychiatry; 2020 Aug; 65(8):568-576. PubMed ID: 32031000
[TBL] [Abstract][Full Text] [Related]
16. Mindfulness-based cognitive therapy for residual depressive symptoms.
Kingston T; Dooley B; Bates A; Lawlor E; Malone K
Psychol Psychother; 2007 Jun; 80(Pt 2):193-203. PubMed ID: 17535594
[TBL] [Abstract][Full Text] [Related]
17. Cognitive reactivity as outcome and working mechanism of mindfulness-based cognitive therapy for recurrently depressed patients in remission.
Cladder-Micus MB; van Aalderen J; Donders ART; Spijker J; Vrijsen JN; Speckens AEM
Cogn Emot; 2018 Mar; 32(2):371-378. PubMed ID: 28278742
[TBL] [Abstract][Full Text] [Related]
18. Mindfulness predicts relapse/recurrence in major depressive disorder after mindfulness-based cognitive therapy.
Michalak J; Heidenreich T; Meibert P; Schulte D
J Nerv Ment Dis; 2008 Aug; 196(8):630-3. PubMed ID: 18974675
[TBL] [Abstract][Full Text] [Related]
19. Added value of Mindfulness-Based Cognitive Therapy for Depression: A Tree-based Qualitative Interaction Analysis.
Ter Avest MJ; Dusseldorp E; Huijbers MJ; van Aalderen JR; Cladder-Micus MB; Spinhoven P; Greven CU; Speckens AEM
Behav Res Ther; 2019 Nov; 122():103467. PubMed ID: 31557693
[TBL] [Abstract][Full Text] [Related]
20. Mindfulness-based cognitive therapy (MBCT) versus the health-enhancement program (HEP) for adults with treatment-resistant depression: a randomized control trial study protocol.
Eisendrath SJ; Gillung EP; Delucchi KL; Chartier M; Mathalon DH; Sullivan JC; Segal ZV; Feldman MD
BMC Complement Altern Med; 2014 Mar; 14():95. PubMed ID: 24612825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
